Carlos Martinez

8PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersBehavioural epidemiologyCardiovascular medicine and haematology not elsewhere classifiedImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 01, 2024
Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low-Molecular-Weight Heparin: The OSCAR-UK Study.

Alexander T Cohen, Christopher Wallenhorst, Marcella Rivera

|Aug 01, 2023
A Novel Risk Prediction Score for Clinically Significant Bleeding in Patients Anticoagulated for Venous Thromboembolism with Active Cancer.

Alexander T Cohen, Christopher Wallenhorst, Satarupa Choudhuri

|Aug 11, 2021
Refined atrial fibrillation screening and cost-effectiveness in the German population.

Renate B Schnabel, Christopher Wallenhorst, Daniel Engler

|Jan 31, 2020
Prediction of significant bleeding during vitamin K antagonist treatment for venous thromboembolism in outpatients.

Carlos Martinez, Anja Katholing, Christopher Wallenhorst

Pageof 2